文献速递静脉血栓栓塞

非癌症手术后静脉血栓栓塞的时间特征与结局

Timing and characteristics of venous thromboembolism after noncancer surgery.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-11-26

基于RIETE注册数据,分析3296例非癌症普通外科术后8周内发生症状性VTE的患者。VTE中位检出时间为术后16天,77%发生于术后第1周后,27%发生于4周后;43.9%曾接受药物预防,中位用药8天;54%表现为肺栓塞,15%结局不良,4%在90天内死亡。

要点

  • 非癌症手术后VTE风险持续至术后2个月,多数事件在出院后检出。
  • 近半数VTE患者曾接受药物预防,但多在停药后发生事件。
  • 超过半数VTE表现为肺栓塞,15%结局不良,需警惕术后延长期风险。

核心结论

  • 非癌症普通外科术后VTE风险持续至术后2个月,多数事件在药物预防停止后检出。
  • 超过半数VTE患者以症状性肺栓塞为首发表现,15%结局不良。

研究设计与样本

  • 基于RIETE注册的前瞻性队列分析,纳入3296例非癌症普通外科术后8周内发生症状性VTE的患者。
  • 主要目标是评估手术至VTE检出的时间间隔,同时记录临床表现、预防用药和不良结局。

主要发现

  • VTE中位检出时间为术后16天(IQR 8-30天),77%在术后第1周后检出,27%在4周后检出。
  • 43.9%的VTE患者术后曾接受药物预防,中位预防时长8天(IQR 5-14天),四分之三的VTE事件在停药后检出。
  • 54%的VTE患者表现为肺栓塞,15%结局不良,其中4%在90天内死亡。

关键数值与推荐

  • VTE中位检出时间:术后16天(IQR 8-30天)。
  • 77%的VTE事件在术后第1周后检出,27%在术后4周后检出。
  • 43.9%的患者接受过药物预防,中位时长8天(IQR 5-14天)。
  • 54%表现为肺栓塞,15%结局不良,4%在90天内死亡。

临床怎么用

  • 非癌症普通外科术后应关注延长期VTE风险,尤其出院后第1周至2个月。
  • 药物预防停药后仍需警惕VTE发生,必要时评估延长预防策略。
  • 术后VTE可表现为肺栓塞,对术后症状性VTE应快速识别和处理。

局限性

  • 仅纳入症状性VTE患者,可能低估无症状VTE的发生率。
  • 为注册登记研究,预防用药方案和停药决策非随机,可能存在混杂。
  • 未报告非癌症手术的具体类型分布和预防指南依从性细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a major cause of morbidity and mortality postoperatively. The use of pharmacologic prophylaxis is effective in reducing the incidence of VTE. However, the prophylaxis is often discontinued at hospital discharge, especially for those with benign disease. The implications of this practice are not known. We assessed the data from a large, ongoing registry regarding the time course of VTE and outcomes after noncancer surgery. METHODS: We analyzed the RIETE (Computerized Registry on Venous Thromboembolism) registry, which includes data from consecutive patients with symptomatic confirmed VTE. In the present study, we focused on general surgical patients who had developed symptomatic postoperative VTE in the first 8 weeks after noncancer surgery. The main objective was to assess the interval between surgery and the occurrence of VTE. Additional variables included the clinical presentation associated with the event, the use of thrombosis prophylaxis, and unfavorable outcomes. RESULTS: The data from 3296 patients were analyzed. The median time from surgery to the detection of VTE was 16 days (interquartile range, 8-30 days). Of the VTE events, 77% were detected after the first postoperative week and 27% after 4 weeks. Overall, 43.9% of the patients with VTE had received pharmacologic prophylaxis after surgery for a median of 8 days (interquartile range, 5-14 days), and three quarters of the VTE events were detected after pharmacologic prophylaxis had been discontinued. Overall, 54% of the patients with VTE had presented with pulmonary embolism. For 15% of the patients, the clinical outcome was unfavorable, including 4% who had died within 90 days. CONCLUSIONS: The risk of VTE after noncancer general surgery remains high for ≤2 months. More than one half of the patients had presented with symptomatic PE as the VTE event, and 15% had had unfavorable outcomes. Only 44% of these patients had received pharmacologic prophylaxis for around 1 week.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Expósito-Ruiz M, Arcelus JI, Caprini JA, et al. Timing and characteristics of venous thromboembolism after noncancer surgery. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33248295. doi:10.1016/j.jvsv.2020.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。